Form 4: SHW Exec Granted 6,060 Stock Options

Sherwin-Williams SVP CHRO Marlena K. Boyce was granted 6,060 employee stock options under the 2025 Equity and Incentive Compensation Plan.

Summary

• Marlena K. Boyce, SVP CHRO of Sherwin-Williams Co. (SHW), reported the acquisition of 6,060 employee stock options.
• The options were granted on October 20, 2025, under the terms of the 2025 Equity and Incentive Compensation Plan.
• Each option has an exercise price of $331.37.
• The options will vest annually in three substantially equal installments, commencing on October 20, 2026.
• The expiration date for these options is October 19, 2035.

Sentiment

Score: 6

Explanation: The grant of stock options to a senior executive is a routine compensation event that aligns management's interests with shareholder value, contributing a slightly positive sentiment.

Positives

• The grant of 6,060 employee stock options to a Senior Vice President and Chief Human Resources Officer (SVP CHRO) aligns management's interests with shareholder value.
• The options are part of the 2025 Equity and Incentive Compensation Plan, indicating a structured approach to executive incentives.

Negatives

• No direct negative information is contained within this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The granted stock options will vest annually in three substantially equal installments, with the first vesting commencing on October 20, 2026, and the options expiring on October 19, 2035.

Industry Context

The grant of stock options to a senior executive is a common practice in publicly traded companies to incentivize long-term performance and align executive interests with shareholder returns. This type of compensation is a standard component of executive remuneration packages across various industries, including the specialty chemicals and coatings sector where Sherwin-Williams operates.

Comparison to Industry Standards

• This filing reports a standard executive compensation event. The grant of stock options with a multi-year vesting schedule is a common incentive mechanism used by companies globally, including peers in the chemicals and manufacturing sectors such as PPG Industries, AkzoNobel, and RPM International.
• The specific number of options (6,060) and exercise price ($331.37) would typically be benchmarked against similar roles and company performance within the industry, though this filing does not provide such comparative data.

Corporate Governance

Related Party Transactions

• The transaction involves an executive (Marlena K. Boyce) and the company (Sherwin-Williams Co.), which is a related party transaction in the context of insider reporting.

Stakeholder Impact

• Shareholders: Potential positive impact through increased alignment of executive incentives with long-term company performance and shareholder value creation.
• Management: The grant provides a significant incentive for the SVP CHRO, linking her compensation to the company's stock performance.

Next Steps

• The options will vest annually in three substantially equal installments, commencing October 20, 2026.

Key Dates

Keywords

Sherwin-Williams, SHW, Stock Options, Executive Compensation, Insider Transaction, Form 4, Equity Incentive Plan, Marlena K. Boyce